Enterprise Value
80.13M
Cash
8.002M
Avg Qtr Burn
-4.119M
Short % of Float
9.81%
Insider Ownership
25.54%
Institutional Own.
14.45%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Plinabulin (Tubulin selective immunomodulating microtubule-binding agent) Details Non-small cell lung carcinoma, Lung cancer | NDA Submission | |
Plinabulin (Tubulin selective immunomodulating microtubule-binding agent) Details Chemotherapy-induced neutropenia, Cancer | NDA Submission |